health
March 11, 2026
Multiple Myeloma Affects Working-Age Population: Early Diagnosis and Modern Therapy Extend Life
Multiple myeloma is the second most common hematological malignancy, and according to data from the Institute of Public Health "Batut," about 520 people in Serbia are diagnosed with this serious disease annually. Approximately 43% of newly diagnosed patients are under 65 years old, representing the potentially working-age population.
TL;DR
- Around 520 people in Serbia are diagnosed with multiple myeloma annually.
- 43% of new cases are patients under 65 years old, representing the working-age population.
- The disease significantly impacts the quality of life for patients and their families.
- The Serbian Medical Society's Myeloma Working Group emphasizes the importance of first-line treatment.
- Belgrade will host the International Myeloma Society Educational Workshop from March 13-14.
- Modern treatment aims for deep and long-lasting remission, leading to a chronic, well-controlled state and a near-normal life expectancy.
- Multiple myeloma is a malignant bone marrow disease characterized by uncontrolled multiplication of plasma cells.
- General practitioners play a key role in early detection through blood tests indicating anemia, elevated proteins, high sedimentation, or impaired kidney function, especially when accompanied by symptoms like fatigue, bone pain, or infections.
- Early detection and access to appropriate modern therapy in all disease stages are crucial for longer, better remissions and preserving patients' daily functioning and dignity.
Continue reading the original article